WASHINGTON, May 30, 2017 /PRNewswire-USNewswire/ -- The Bio-Process Systems Alliance (BPSA) is pleased to announce
Technical topics will be blended with business and regulatory presentations to provide a mix of issues that surround the rapid global emergence of single-use as the "go-to" platform in bioprocessing.
"This unique coupling of technical, business and political topics is the key to the value of our program again for 2017," said John Boehm of CPC, Chairman of BPSA's Board of Directors. "For component manufacturers, system integrators and especially users, it is evident that single-use is poised for long-term market growth. We will take an in-depth look at key technical topics, as well as provide context to the current business climate, inclusive of government initiatives and projected market growth. It's going to be interesting and informative for all."
Topics and presenters include:
"With the 2017 Summit, our seventh consecutive annual event, we have again put together a program that will appeal to CEOs, manufacturing VPs, quality-assurance experts, single-use systems integrators, educators and vaccine and biopharma providers," said Kevin Ott, Executive Director of BPSA. "This meeting is dedicated to addressing everything you need to know about single-use…right now."
The Summit will be held at the Four Seasons Hotel Georgetown in Washington, D.C. The full agenda, registration and hotel information can be viewed at www.bpsalliance.org.
About BPSAThe Bio-Process Systems Alliance (BPSA) was formed in 2005 as an industry-led corporate member trade association dedicated to encouraging and accelerating the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines. For more information, please visit www.bpsalliance.org, or contact Kevin Ott, Executive Director, at email@example.com.
Contact:Kevin OttExecutive DirectorBPSA(202) firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bpsas-7th-annual-business-summit-to-focus-on-key-single-use-attributes-driving-current-and-future-markets-300464693.html
SOURCE Bio-Process Systems Alliance (BPSA)
Subscribe to our Free Newsletters!
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...
Aniridia is a genetic eye disorder in which the iris is partially or entirely absent. It is ...
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...View All